research

Enzymatic doped ionogels - new materials for inherently biocompatible molecular sensors

Abstract

• The key challenges currently faced in lab-on-a-chip biochemical sensor developments are device reliability and power consumption. • Point-of-care (POC) glucose biosensors play an important role in the management of blood sugar levels in patients with diabetes. Glucose biosensors still account for approximately 85% of the current world market which is estimated to be worth $5 billon. • Ionic liquids (ILs) have evolved as a new type of solvent for biocatalysis, mainly due to their unique and tunable physical properties

    Similar works